Bryant Furlow

Bryant Furlow is medical journalist working at the crossroads of research, clinical practice, and public policy. His work has appeared The Lancet, New Scientist, and Oncology Nurse Advisor.

Most Recent Articles by Bryant Furlow

Does Education Level Predict PSA Screening and Prostate Cancer Survival?

Does Education Level Predict PSA Screening and Prostate Cancer Survival?

By

Socioeconomic status, including education and income level, appears to be tied to prostate-specific antigen test results and prostate cancer treatment and survival, but the exact nature of these associations is not yet clear.

Can Targeting Inflammatory Microenvironments Improve Cancer Therapy Effectiveness?

Can Targeting Inflammatory Microenvironments Improve Cancer Therapy Effectiveness?

By

Targeting tumor and extracellular LPA could help deny tumors their inflammatory habitat and improve the efficacy of radiotherapy, chemotherapy, and possibly immunotherapies.

Nano-pulse Stimulation Shows Early Preclinical Promise

Nano-pulse Stimulation Shows Early Preclinical Promise

By

NPS with electrodes is under investigation as a potential new ablative — and possibly immunotherapeutic — cancer treatment modality.

Alcohol Is A Modifiable Risk Factor for Cancer, According to ASCO Special Report

Alcohol Is A Modifiable Risk Factor for Cancer, According to ASCO Special Report

By

Seventy percent of Americans surveyed in this year's National Cancer Opinion Survey were unaware that alcohol is a well-established and modifiable risk factor for cancer, the authors noted.

Genetic Predisposition to Cancer: Where Are We Now?

Genetic Predisposition to Cancer: Where Are We Now?

By

In part 2 of a 2-part series, Bryant Furlow discusses advances in genome sequencing technologies and the resulting insights into associations between inherited germline mutations and cancer.

More Articles by Bryant Furlow

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters